Julie A. Vetalice, Author at ORTHOWORLD

Active Implants Announces 1st Meniscus Replacement in SUN Clinical Trial

Active Implants announced the first meniscus replacement in the SUN (Safety Using NUsurface®) clinical trial for patients with persistent knee pain following medial meniscus surgery.

May 23, 2016

NuVasive Announces U.S. Launch of AttraX® Putty

Orthobiologics ORTHOFLASH

NuVasive announced the U.S. launch of AttraX® Putty, a synthetic bone graft for use in the posterior lateral spine.

May 23, 2016

Implanet Receives FDA Clearance and CE Mark for Jazz Claw Implant

ORTHOFLASH Spine

Implanet received FDA 510(k) clearance and CE Mark approval for the Jazz Claw®, a hybrid implant designed to treat degenerative spinal pathologies.

May 23, 2016

JNJ’s Business Review Day Highlights Company Priorities and Restructuring

Company Updates Competitive Landscape

Johnson & Johnson/JNJ's business review day on May 18 filled some gaps in my understanding of the restructuring picture, but some holes remain. Here is what we learned, and what we don't know yet.

May 23, 2016

Medacta Reports on Device Utilization

Joint Replacement ORTHOFLASH

Results from a 421-patient study revealed a 97.75% survival rate at 5 years for Medacta’s AMIStem hip implant. AMIStem has been implanted >100,000 times, to date.

May 19, 2016

Vertebral Technologies Launches InterGraft Biologics

Orthobiologics ORTHOFLASH

Vertebral Technologies launched the InterGraft™ series of 100% DBM osteoinductive scaffolds.

May 19, 2016

Medtronic Announces U.S. Launch of Spine Essentials

ORTHOFLASH Spine

Medtronic commenced U.S. launch of Spine Essentials™, implants and instruments designed to lend efficiency to the most common cervical fusion procedures.

May 19, 2016

New Bone Therapeutics Phase II Trial of ALLOB for Severe Osteoporosis

Orthobiologics ORTHOFLASH

Bone Therapeutics is planning a Phase II trial with ALLOB® allogeneic bone cell therapy for the treatment of severe osteoporosis.

May 19, 2016

Bone Solutions Receives $1.7MM in Funding

Investments The Numbers

Bone Solutions closed a funding round for a total of >US $1.7MM, and affirmed an additional $1.65MM commitment from Next Health, its distribution partner.

May 19, 2016

Anika Therapeutics Launches CINGAL in Canada

Orthobiologics ORTHOFLASH

Anika Therapeutics announced Canada launch of CINGAL® viscosupplement, cleared to treat knee osteoarthritis pain. CINGAL will be marketed by Pendopharm.

May 19, 2016

Get the ORTHOWORLD Newsletter!

Contact Us